Simplex Trading’s Lunai Bioworks LNAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-51
Closed -$7K 9384
2024
Q2
$7K Sell
51
-117
-70% -$15.9K ﹤0.01% 7694
2024
Q1
$35K Buy
+168
New +$45.3K ﹤0.01% 6612
2022
Q4
Sell
-283
Closed -$40K 10208
2022
Q3
$40K Sell
283
-853
-75% -$155K ﹤0.01% 6737
2022
Q2
$175K Buy
1,136
+992
+689% +$454K ﹤0.01% 4779
2022
Q1
$94K Buy
144
+139
+2,780% +$74K ﹤0.01% 6242
2021
Q4
$2K Buy
+5
New +$3.63K ﹤0.01% 10040

Other funds holding LNAI

Simplex Trading's LNAI Position: Q1 2026 in Review

Simplex Trading reduced its Lunai Bioworks (LNAI) stake by 90% in Q1 2026, selling an estimated $6.09K and leaving 138 shares worth $451. The position accounts for ﹤0.01% of the portfolio, ranked #8742.

Simplex Trading first reported a position in LNAI in Q4 2021 and has held it in 12 quarters since. The position peaked at $12K in Q4 2021. 27 funds tracked by Wall St. Rank hold LNAI as of Q1 2026.

  • Simplex Trading held 138 shares of Lunai Bioworks worth $451 as of Q1 2026.
  • Simplex Trading sold 1,227 Lunai Bioworks shares in Q1 2026, an estimated $6.09K.
  • Lunai Bioworks made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8742 holding.
  • Simplex Trading first reported a position in Lunai Bioworks in Q4 2021 and has held it in 12 quarters since.
  • Simplex Trading's Lunai Bioworks position peaked at $12K in Q4 2021.
  • 27 funds tracked by Wall St. Rank held Lunai Bioworks as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.